MITRA RXDX INC has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets computer technology, biotechnology and measurement are COYNE IP HOLDINGS LLC, IGNITE BIOSCIENCES INC and VIRCO NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Computational chemistry | |
#3 | Microorganisms | |
#4 | Bioinformatics | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Goldman Aaron | 12 |
#2 | Majumder Pradip K | 8 |
#3 | Radhakrishnan Padhma D | 7 |
#4 | Majumder Pradip | 4 |
#5 | Majumder Biswanath | 3 |
#6 | Rahdhakrishnan Padhma | 3 |
#7 | Thiyagarajan Saravanan | 2 |
#8 | Radhakrishnan Padhma | 1 |
#9 | Cassidy James | 1 |
#10 | Cassidy James P | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020172592A1 | A method to predict a patient's response to an anti-cancer drug from a ratio of expression levels of two sets of genes | |
WO2019164951A1 | Methods of predicting response to temporally sequenced combination therapy | |
WO2018148336A1 | Method of predicting clinical outcome of anticancer agents |